Stratec SE (Stratec SE) Forward Dividend Yield % : 0.00% (As of May. 26, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Forward Dividend Yield %?

As of today (2024-05-26), the Forward Annual Dividend Yield of Stratec SE is 0.00%.

As of today (2024-05-26), the Trailing Annual Dividend Yield of Stratec SE is 0.00%.

SBMDY's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.96
* Ranked among companies with meaningful Forward Dividend Yield % only.

Stratec SE's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

During the past 12 months, Stratec SE's average Dividends Per Share Growth Rate was 2.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Stratec SE was 77.10% per year. The lowest was 2.90% per year. And the median was 8.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Stratec SE's Forward Dividend Yield %

For the Medical Devices subindustry, Stratec SE's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stratec SE's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Stratec SE's Forward Dividend Yield % falls into.

Stratec SE Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Stratec SE (OTCPK:SBMDY) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Stratec SE Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Stratec SE's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stratec SE (Stratec SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

SBS:Germany

Address

Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217

Website

https://www.stratec.com

Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus

STRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech Plastics

By ACCESSWIRE ACCESSWIRE • 06-07-2023